Elekta Management

Management criteria checks 4/4

Elekta's CEO is Gustaf Salford, appointed in Jun 2020, has a tenure of 3.83 years. total yearly compensation is SEK18.35M, comprised of 40.3% salary and 59.7% bonuses, including company stock and options. directly owns 0.015% of the company’s shares, worth SEK4.36M. The average tenure of the management team and the board of directors is 5.3 years and 10 years respectively.

Key information

Gustaf Salford

Chief executive officer

kr18.3m

Total compensation

CEO salary percentage	40.3%
CEO tenure	3.8yrs
CEO ownership	0.02%
Management average tenure	5.3yrs
Board average tenure	10yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Gustaf Salford's remuneration changed compared to Elekta's earnings?
Date	Total Compensation	Salary	Company Earnings
Jan 31 2024	n/a	n/a	kr1b
Oct 31 2023	n/a	n/a	kr1b
Jul 31 2023	n/a	n/a	kr1b
Apr 30 2023	kr18m	kr7m	kr943m
Jan 31 2023	n/a	n/a	kr813m
Oct 31 2022	n/a	n/a	kr826m
Jul 31 2022	n/a	n/a	kr1b
Apr 30 2022	kr15m	kr8m	kr1b
Jan 31 2022	n/a	n/a	kr1b
Oct 31 2021	n/a	n/a	kr1b
Jul 31 2021	n/a	n/a	kr1b
Apr 30 2021	kr13m	kr4m	kr1b

Compensation vs Market: Gustaf's total compensation ($USD1.69M) is below average for companies of similar size in the UK market ($USD2.64M).

Compensation vs Earnings: Gustaf's compensation has been consistent with company performance over the past year.

CEO

Gustaf Salford (46 yo)

3.8yrs

Tenure

kr18,348,000

Compensation

Mr. Gustaf Salford serves as President and Chief Executive Officer at Elekta AB (publ) since November 26, 2020 and served as its Acting President and Chief Executive Officer since June 2, 2020 until Novemb...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Laurent Leksell	Founder & Chairman	52.3yrs	kr1.64m	5.99% SEK 1.7b
Gustaf Salford	President & CEO	3.8yrs	kr18.35m	0.015% SEK 4.4m
Tobias Hagglov	Chief Financial Officer	2.2yrs	no data	0.0040% SEK 1.1m
Peter Nyquist	Head of Investor Relations	no data	no data	no data
Jonas Bolander	Executive VP of Group Functions	7.4yrs	no data	0.0062% SEK 1.7m
Mattias Thorsson	VP and Head of Corporate Communications & Public Affairs	no data	no data	no data
Anna Lundgren	Executive VP & Chief People Officer	1.3yrs	no data	0.00082% SEK 231.5k
John Lapré	President of Brachy & Neuro Solutions	11.8yrs	no data	0.0074% SEK 2.1m
Maurits Wolleswinkel	President of Linac & Software Solutions	9.7yrs	no data	0.0096% SEK 2.7m
Habib Nehme	Chief Commercial Officer	5.3yrs	no data	0.0013% SEK 369.9k
Hilma Nordquist	Global Sustainability Director	no data	no data	no data
John Christodouleas	Head of Medical Affairs	no data	no data	no data

5.3yrs

Average Tenure

57yo

Average Age

Experienced Management: 0O5H's management team is seasoned and experienced (5.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Laurent Leksell	Founder & Chairman	52.3yrs	kr1.64m	5.99% SEK 1.7b
Jan Secher	Independent Director	14.3yrs	kr815.00k	0.010% SEK 2.9m
Wolfgang Reim	Independent Director	13.3yrs	kr740.00k	0.0067% SEK 1.9m
Tomas Eliasson	Independent Director	less than a year	no data	no data
Birgitta Goransson	Independent Director	19.3yrs	kr910.00k	0.0021% SEK 598.6k
Volker Wetekam	Director	less than a year	no data	no data
Caroline Cooke	Director	6.7yrs	kr815.00k	0.048% SEK 13.5m
Cecilia Wikström	Independent Director	5.7yrs	kr740.00k	0.0022% SEK 635.3k

10.0yrs

Average Tenure

63.5yo

Average Age

Experienced Board: 0O5H's board of directors are considered experienced (10 years average tenure).

Elekta Management

Management criteria checks 4/4

Key information

Recent management updates

Elekta AB (publ) Announces Resignation of Kelly Londy, Member of the Board

Elekta AB (publ) Announces Composition of Nomination Committee

Elekta AB (publ), Annual General Meeting, Sep 05, 2024

Founder & Chairman recently sold kr60m worth of stock

President & CEO recently bought kr501k worth of stock

Johan Malmquist Declines Re-Election as Director of Elekta AB (Publ)

Recent updates

Elekta AB (publ) Announces Resignation of Kelly Londy, Member of the Board

Third quarter 2024 earnings released: EPS: kr0.80 (vs kr0.56 in 3Q 2023)

Elekta AB (publ) to Report Q2, 2025 Results on Nov 27, 2024

Upcoming dividend of kr1.20 per share

Second quarter 2024 earnings released: EPS: kr0.90 (vs kr0.32 in 2Q 2023)

Elekta AB (publ) to Report Fiscal Year 2024 Final Results on Jul 05, 2024

Elekta AB (publ) Announces Composition of Nomination Committee

Elekta AB (publ) (OM:EKTA B) agreed to acquire Xoft, Inc. from iCAD, Inc. (NasdaqCM:ICAD).

Elekta AB (publ), Annual General Meeting, Sep 05, 2024

Founder & Chairman recently sold kr60m worth of stock

First quarter 2024 earnings released: EPS: kr0.62 (vs kr0.16 in 1Q 2023)

Elekta AB (Publ) Approves Dividend, Payable on 31 August, 2023 and 1 March, 2024, Respectively

Upcoming dividend of kr1.20 per share at 3.1% yield

Full year 2023 earnings released: EPS: kr2.47 (vs kr3.02 in FY 2022)

President & CEO recently bought kr501k worth of stock

Johan Malmquist Declines Re-Election as Director of Elekta AB (Publ)

Now 20% undervalued

Elekta AB (publ) to Report Q3, 2024 Results on Feb 09, 2024

Full year 2023 earnings released: EPS: kr2.47 (vs kr3.02 in FY 2022)

Elekta AB (publ) Provides Earnings Guidance for the Fiscal Year from 2022-2023 to 2024-2025

Elekta AB (Publ) Announces the Launch of the First Phase of Elekta ONE

Third quarter 2023 earnings released

Upcoming dividend of kr1.20 per share at 3.1% yield

Elekta AB (publ) (OM:EKTA B) entered into an agreement to acquire business assets of Premier Business Inter.

Elekta AB (publ) (OM:EKTA B) entered into an agreement to acquire business assets of Premier Business Inter.

Independent Director recently bought kr63k worth of stock

First Ever Patient Treated for Pancreatic Cancer with New Advanced Radiotherapy Motion Management Using Elekta Unity MR-Linac

Second quarter 2023 earnings released

Elekta AB (publ), Annual General Meeting, Aug 24, 2023

Swedish and Jordanian Royalty Inaugurate Elekta AB (publ) Radiation Therapy Devices for Cancer and Brain Disease

Insufficient new directors

Elekta AB (publ) Announces Elekta Esprit Receives FDA 510(k) Clearance

Elekta Unity Demonstrates Promising Quality of Life Outcomes for Pancreas and Prostate Cancers At Astro Annual Meeting

Elekta AB (publ)(OM:EKTA B) dropped from FTSE All-World Index (USD)

Elekta AB (publ) Elects Kelly Londy as a Director

First quarter 2023 earnings released: EPS: kr0.16 (vs kr0.33 in 1Q 2022)

Upcoming dividend of kr1.20 per share

Full year 2022 earnings released: EPS: kr3.02 (vs kr3.28 in FY 2021)

Elekta AB (publ) to Report Fiscal Year 2023 Results on May 25, 2023

Chief Product Officer recently bought kr420k worth of stock

Full year 2022 earnings released: EPS: kr3.02 (vs kr3.28 in FY 2021)

Elekta AB (Publ) Proposes Dividend for the Fiscal Year 2021/22

Elekta Launches New Radiosurgery System: Elekta Esprit

Insufficient new directors

Elekta AB (publ) to Report Fiscal Year 2022 Final Results on Jul 08, 2022

Insider recently bought kr518k worth of stock

Third quarter 2022 earnings: Revenues in line with analyst expectations

Elekta AB (publ), Annual General Meeting, Aug 25, 2022

Investor sentiment deteriorated over the past week

Upcoming dividend of kr1.10 per share

President of Brachy Solutions recently bought kr305k worth of stock

Independent Director recently bought kr1.1m worth of stock

Second quarter 2022 earnings: Revenues exceed analyst expectations

Founder & Chairman recently bought kr49m worth of stock

Elekta AB (publ) (OM:EKTA B) acquired Özyürek Mümessillik ve Dis Ticaret A.S.

First quarter 2022 earnings released: EPS kr0.33 (vs kr0.56 in 1Q 2021)

Upcoming dividend of kr1.10 per share

Full year 2021 earnings released: EPS kr3.28 (vs kr2.84 in FY 2020)

President & CEO recently bought kr1.0m worth of stock

Elekta AB (Publ)'s Elekta Harmony Radiation Therapy System Receives U.S. FDA 510(K) Clearance

CFO & Group Treasurer recently bought kr492k worth of stock

Full year 2021 earnings released: EPS kr3.28 (vs kr2.84 in FY 2020)

Elekta AB (Publ) Proposes Dividend for the Fiscal Year 2021

Elekta AB (Publ) Approves Extra Dividend, Payable on 23 April 2021

Elekta AB (publ) Proposes Extra Dividend, Payable on 23 April 2021

Elekta and IBA Strengthen Partnership to Help Cancer Centers Integrate Proton Therapy

Elekta Not Provides Earnings Guidance for the Year of 2021

First Cancer Centers Begin Using Initial Release of Elekta's MOSAIQ 3 Series

Elekta AB (publ) (OM:EKTA B) signed an agreement to acquire Oncology division from Horizon for Medical Appliances.